Get 20% lifetime commission for referring investors to digrin.com
here.
Eliem Therapeutics, Inc (ELYM) Financials
Stock symbol ELYM is outdated, potentially delisted? Maybe it is available on other exchange?
ELYM Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2023 | 112.7 million | 3.0 million |
| June 30, 2023 | 116.3 million | 3.8 million |
| March 31, 2023 | 122.1 million | 5.2 million |
| Dec. 31, 2022 | 135.0 million | 6.3 million |
ELYM Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2023 | 3.5 million | 656000 |
| June 30, 2023 | -8.0 million | 777000 |
| March 31, 2023 | -15.2 million | 10.2 million |
| Dec. 31, 2022 | -8.4 million | 1.9 million |
ELYM Net Income
No data available :(
ELYM Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2023 | 107.4 million | - | 459000 |
| June 30, 2023 | 102.6 million | - | 585000 |
| March 31, 2023 | 109.4 million | - | 687000 |
| Dec. 31, 2022 | 123.6 million | - | 480000 |
ELYM Shares Outstanding
ELYM Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2023 | - | 2.9 million | 2.1 million | - |
| June 30, 2023 | - | 3.7 million | 3.0 million | - |
| March 31, 2023 | - | 5.7 million | 17.7 million | - |
| Dec. 31, 2022 | - | 4.9 million | 4.6 million | - |
ELYM Cost of Revenue
No data available :(
ELYM
Price: $5.11
52 week price:
Earnings Per Share: -2.22 USD
P/E Ratio: -1.85
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 3200
Market Capitalization: 342.7 million